# Jeffrey N. Weitzel

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jeffrey-n-weitzel/

## Facts

| Field | Value |
| --- | --- |
| Citations | 32,720 |
| Field | BRCA gene mutations in cancer |
| h-index | 89 |
| i10-index | 275 |
| Last Known Institution | The University of Kansas Cancer Center |
| OpenAlex ID | https://openalex.org/A5029960276 |
| ORCID iD | https://orcid.org/0000-0001-6714-092X |
| Works | 669 |

## Researcher papers

- [Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial](https://scholariq.org/papers/oral-poly-adp-ribose-polymerase-inhibitor-olaparib-in-patients-with-brca1-or/)
- [Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/genetic-familial-high-risk-assessment-breast-ovarian-and-pancreatic-version-2/)
- [A Population-Based Study of Genes Previously Implicated in Breast Cancer](https://scholariq.org/papers/a-population-based-study-of-genes-previously-implicated-in-breast-cancer/)
- [NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017](https://scholariq.org/papers/nccn-guidelines-insights-genetic-familial-high-risk-assessment-breast-and/)
- [Genetic/Familial High-Risk Assessment: Breast and Ovarian](https://scholariq.org/papers/genetic-familial-high-risk-assessment-breast-and-ovarian/)
- [NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020](https://scholariq.org/papers/nccn-guidelines-insights-genetic-familial-high-risk-assessment-breast-ovarian/)
- [Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer](https://scholariq.org/papers/association-of-type-and-location-of-i-brca1-i-and-i-brca2-i-mutations-with-risk/)
- [Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk](https://scholariq.org/papers/genome-wide-association-study-in-brca1-mutation-carriers-identifies-novel-loci/)
- [Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer](https://scholariq.org/papers/personalized-circulating-tumor-dna-analysis-to-detect-residual-disease-after/)
- [Identification of six new susceptibility loci for invasive epithelial ovarian cancer](https://scholariq.org/papers/identification-of-six-new-susceptibility-loci-for-invasive-epithelial-ovarian/)
- [Prediction of Breast and Prostate Cancer Risks in Male <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers Using Polygenic Risk Scores](https://scholariq.org/papers/prediction-of-breast-and-prostate-cancer-risks-in-male-i-brca1-i-and-i-brca2-i/)

## Researcher topics

- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [Nutrition, Genetics, and Disease](https://scholariq.org/topics/nutrition-genetics-and-disease/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [DNA Repair Mechanisms](https://scholariq.org/topics/dna-repair-mechanisms/)

## Researcher university

- [The University of Kansas Cancer Center](https://scholariq.org/institutions/the-university-of-kansas-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.